{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:38:06Z","timestamp":1783471086551,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41390-021-01882-z","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T09:02:46Z","timestamp":1640336566000},"page":"1099-1107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lupus nephritis with corticosteroid responsiveness: molecular changes of CD46-mediated type 1 regulatory T cells"],"prefix":"10.1038","volume":"92","author":[{"given":"Yi-Giien","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jien-Wen","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ming","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Fang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"1882_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.it.2011.03.010","volume":"32","author":"A Cope","year":"2011","unstructured":"Cope, A., Le Friec, G., Cardone, J. & Kemper, C. The Th1 life cycle: molecular control of IFN- g to IL-10 swiching. Trends Immunol. 32, 278\u2013286 (2011).","journal-title":"Trends Immunol."},{"key":"1882_CR2","doi-asserted-by":"publisher","first-page":"432595","DOI":"10.1155\/2011\/432595","volume":"2011","author":"K Ohl","year":"2011","unstructured":"Ohl, K. & Tenbrock, K. Inflammatory cytokines in systemic lupus erythematosus. J. Biomed. Biotechnol. 2011, 432595 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"1882_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3899\/jrheum.121299","volume":"40","author":"L Abeler-D\u00f6rner","year":"2013","unstructured":"Abeler-D\u00f6rner, L. et al. Interferon-\u03b1 abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis. J. Rheumatol. 40, 1683\u20131696 (2013).","journal-title":"J. Rheumatol."},{"key":"1882_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/art.23268","volume":"58","author":"B Yan","year":"2008","unstructured":"Yan, B. et al. Dysfunctional CD4+CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 58, 801\u2013812 (2008).","journal-title":"Arthritis Rheum."},{"key":"1882_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrrheum.2017.125","volume":"13","author":"LA Trouw","year":"2017","unstructured":"Trouw, L. A., Pickering, M. C. & Blom, A. M. The complement system as a potential therapeutic target in rheumatic disease. Nat. Rev. Rheumatol. 13, 538\u2013547 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1882_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaut.2006.06.005","volume":"27","author":"B Alvarado-Sanchez","year":"2006","unstructured":"Alvarado-Sanchez, B. et al. Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 27, 110\u2013118 (2006).","journal-title":"J. Autoimmun."},{"key":"1882_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00403-008-0891-9","volume":"301","author":"A Kuhn","year":"2009","unstructured":"Kuhn, A., Beissert, S. & Krammer, P. H. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch. Dermatol Res. 301, 71\u201381 (2009).","journal-title":"Arch. Dermatol Res."},{"key":"1882_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva, M. & Garra, O. A. The regulation of IL-10 production by immune cells. Net. Rev. Immunol. 10, 170\u2013181 (2010).","journal-title":"Net. Rev. Immunol."},{"key":"1882_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/ar2894","volume":"12","author":"DA Horwitz","year":"2010","unstructured":"Horwitz, D. A. Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res Ther. 12, 101 (2010).","journal-title":"Arthritis Res Ther."},{"key":"1882_CR10","doi-asserted-by":"publisher","first-page":"i65","DOI":"10.1136\/ard.2009.117135","volume":"69","author":"M Bonelli","year":"2010","unstructured":"Bonelli, M., Smolen, J. S. & Scheinecker, C. Treg and lupus. Ann. Rheum. Dis. 69, i65\u2013i66 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1882_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/rheumatology\/ken108","volume":"47","author":"HY Lee","year":"2008","unstructured":"Lee, H. Y., Hong, Y. K., Yun, H. J., Kim, Y. M. & Yoo, W. H. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology 47, 789\u2013794 (2008).","journal-title":"Rheumatology"},{"key":"1882_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.autrev.2011.09.008","volume":"11","author":"P Sawla","year":"2012","unstructured":"Sawla, P., Hossain, A., Hahn, B. H. & Singh, R. P. Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance. Autoimmun. Rev. 11, 611\u2013614 (2012).","journal-title":"Autoimmun. Rev."},{"key":"1882_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737\u2013742 (1997).","journal-title":"Nature"},{"key":"1882_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","volume":"49","author":"MG Roncarolo","year":"2018","unstructured":"Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M. & Gagliani, N. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49, 1004\u20131019 (2018).","journal-title":"Immunity"},{"key":"1882_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/ni.1917","volume":"11","author":"J Cardone","year":"2010","unstructured":"Cardone, J. et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862\u2013871 (2010).","journal-title":"Nat. Immunol."},{"key":"1882_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ni.2454","volume":"13","author":"G Le Friec","year":"2012","unstructured":"Le Friec, G. et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat. Immunol. 13, 1213\u20131221 (2012).","journal-title":"Nat. Immunol."},{"key":"1882_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2015.05.024","volume":"42","author":"M Kolev","year":"2015","unstructured":"Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 42, 1033\u20131047 (2015).","journal-title":"Immunity"},{"key":"1882_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2567.2008.02821.x","volume":"124","author":"AL Astier","year":"2008","unstructured":"Astier, A. L. T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology 124, 149\u2013154 (2008).","journal-title":"Immunology"},{"key":"1882_CR19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/labinvest.2012.86","volume":"92","author":"YG Tsai","year":"2012","unstructured":"Tsai, Y. G. et al. Functional defects of CD46-induced regulatory T cells to suppress airway inflammation in mite allergic asthma. Lab Invest. 92, 1260\u20131269 (2012).","journal-title":"Lab Invest."},{"key":"1882_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature01315","volume":"421","author":"C Kemper","year":"2003","unstructured":"Kemper, C. et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388\u2013392 (2003).","journal-title":"Nature"},{"key":"1882_CR21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jaci.2014.06.005","volume":"134","author":"YG Tsai","year":"2014","unstructured":"Tsai, Y. G. et al. Enhanced CD46-induced regulatory T cells suppress allergic inflammation after Dermatophagoides pteronyssinus-specific immunotherapy. J. Allergy Clin. Immunol. 134, 1206\u20131209 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1882_CR22","doi-asserted-by":"publisher","first-page":"725684","DOI":"10.1155\/2012\/725684","volume":"2012","author":"AP Alegretti","year":"2012","unstructured":"Alegretti, A. P. et al. Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients. Clin. Dev. Immunol. 2012, 725684 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"1882_CR23","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/ar3539","volume":"13","author":"A Jonsen","year":"2011","unstructured":"Jonsen, A. et al. Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res. Ther. 13, R206 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"1882_CR24","first-page":"659","volume":"3","author":"JC Marie","year":"2005","unstructured":"Marie, J. C. et al. Linking innate and acquired immunity: divergent role of CD46 induces a T-regulatory cell 1 phenotype. Nature 3, 659\u2013666 (2005).","journal-title":"Nature"},{"key":"1882_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/ard.2005.049924","volume":"65","author":"A Su\u00e1rez","year":"2006","unstructured":"Su\u00e1rez, A., L\u00f3pez, p, G\u00f3mez, J. & Guti\u00e9rrez, C. Enrichment of CD4+CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann. Rheum. Dis. 65, 1512\u20131517 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"1882_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0961203307077990","volume":"16","author":"AM Cepika","year":"2007","unstructured":"Cepika, A. M., Marinic, i, Morovic-vergles, J., Soldo-Juresa, D. & Gagro, A. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 16, 374\u2013377 (2007).","journal-title":"Lupus"},{"key":"1882_CR27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/1529-0131(199907)42:7<1354::AID-ANR8>3.0.CO;2-4","volume":"42","author":"HI Brunner","year":"1999","unstructured":"Brunner, H. I., Feldman, B. M., Bombardier, C. & Silverman, E. D. Sensitivity of the systemic lupus erythematosus disease activity index, British Isles Lupus Assessment Group Index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 42, 1354\u20131360 (1999).","journal-title":"Arthritis Rheum."},{"key":"1882_CR28","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman, D. D., Ibanez, D. & Urowitz, M. B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 29, 288\u2013291 (2002).","journal-title":"J. Rheumatol."},{"key":"1882_CR29","doi-asserted-by":"publisher","first-page":"e81344","DOI":"10.1371\/journal.pone.0081344","volume":"9","author":"YG Tsai","year":"2014","unstructured":"Tsai, Y. G., Lee, C. Y., Lin, T. Y. & Lin, C. Y. CD8+ Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria. PLoS ONE 9, e81344 (2014).","journal-title":"PLoS ONE"},{"key":"1882_CR30","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/eji.201646822","volume":"47","author":"U Ellinghaus","year":"2017","unstructured":"Ellinghaus, U. et al. Dysregulated CD46 shedding inferes with Th1-contraction in systemic lupus erythematosus. Eur. J. Immunol. 47, 1200\u20131210 (2017).","journal-title":"Eur. J. Immunol."},{"key":"1882_CR31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","volume":"39","author":"MK Liszewski","year":"2013","unstructured":"Liszewski, M. K. et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentation. Immunity 39, 1143\u20131157 (2013).","journal-title":"Immunity"},{"key":"1882_CR32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1083\/jcb.200109005","volume":"156","author":"SW Lee","year":"2002","unstructured":"Lee, S. W. et al. CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrboeae. J. Cell Biol. 156, 951\u2013957 (2002).","journal-title":"J. Cell Biol."},{"key":"1882_CR33","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.4049\/jimmunol.164.4.1839","volume":"164","author":"G Wang","year":"2000","unstructured":"Wang, G., Liszewski, M., Chan, A. & Atkinson, J. P. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J. Immunol. 164, 1839\u20131846 (2000).","journal-title":"J. Immunol."},{"key":"1882_CR34","doi-asserted-by":"publisher","first-page":"e16287","DOI":"10.1371\/journal.pone.0016287","volume":"6","author":"S Ni Choileain","year":"2011","unstructured":"Ni Choileain, S. et al. The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activation. PLoS ONE 6, e16287 (2011).","journal-title":"PLoS ONE"},{"key":"1882_CR35","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1046\/j.1523-1755.1998.00130.x","volume":"54","author":"M Nangaku","year":"1998","unstructured":"Nangaku, M. Complement regulatory proteins in glomerular diseases. Kidney Int. 54, 1419\u20131428 (1998).","journal-title":"Kidney Int."},{"key":"1882_CR36","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.18632\/oncotarget.23907","volume":"9","author":"MH Tseng","year":"2018","unstructured":"Tseng, M. H. et al. Serum complement factor I is associated with disease activity of systemic lupus erythematosus. Oncotarget 9, 8502\u20138511 (2018).","journal-title":"Oncotarget"},{"key":"1882_CR37","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1182\/bloodadvances.2018019596","volume":"2","author":"MH Park","year":"2018","unstructured":"Park, M. H., Caselman, N., Ulmer, S. & Weitz, I. C. Complement-mediated thrombotic microangiopathy associated with lupus nephritis. Blood Adv. 2, 2090\u20132094 (2018).","journal-title":"Blood Adv."},{"key":"1882_CR38","first-page":"1559","volume":"35","author":"P Lopez","year":"2008","unstructured":"Lopez, P., Gomez, J., Prado, C., Gutierrez, C. & Suarez, A. Influence of functional interleukin 10\/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J. Rheumatol. 35, 1559\u20131566 (2008).","journal-title":"J. Rheumatol."},{"key":"1882_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/art.10112","volume":"46","author":"M Yamada","year":"2002","unstructured":"Yamada, M. et al. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis. Arthritis Rheum. 46, 735\u2013740 (2002).","journal-title":"Arthritis Rheum."},{"key":"1882_CR40","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.4049\/jimmunol.181.4.2544","volume":"181","author":"SK Alford","year":"2008","unstructured":"Alford, S. K., Longmore, G. D., Stenson, W. F. & Kemper, C. CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J. Immunol. 181, 2544\u20132555 (2008).","journal-title":"J. Immunol."},{"key":"1882_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/prcm.prcm_5_18","volume":"3","author":"CY Lin","year":"2019","unstructured":"Lin, C. Y. & Tsai, Y. G. Complements and allergic asthma. Pediatr. Respirol. Crit. Care Med 3, 3\u20137 (2019).","journal-title":"Pediatr. Respirol. Crit. Care Med"},{"key":"1882_CR42","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.4049\/jimmunol.177.8.4957","volume":"177","author":"G Meiffren","year":"2006","unstructured":"Meiffren, G., Flacher, M., Azocar, O., Rabourdin-Combe, C. & Faure, M. Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt\/Survivin signaling pathway. J. Immunol. 177, 4957\u20134961 (2006).","journal-title":"J. Immunol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01882-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01882-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01882-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T18:02:59Z","timestamp":1666461779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01882-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01882-z","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"assertion":[{"value":"13 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from each participant and their guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}